• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC - GALWAY SYNERGY II EVEROLIMUS-ELUTING PLATINUM CHROMIUM CORONARY STENT SYSTEM; BIODEGRADABLE POLYMER DRUG ELUTING CORONARY STENT SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC - GALWAY SYNERGY II EVEROLIMUS-ELUTING PLATINUM CHROMIUM CORONARY STENT SYSTEM; BIODEGRADABLE POLYMER DRUG ELUTING CORONARY STENT SYSTEM Back to Search Results
Model Number H7493926020300
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problem Prolapse (2475)
Event Date 05/20/2018
Event Type  Injury  
Manufacturer Narrative
Device is a combination product.Device evaluated by mfr: the device has not been received for analysis.Upon receipt and completion of the failure analysis of the complaint device, if there is any further relevant information from that review, a supplemental medwatch will be filed.Bsc id: (b)(4).Tw: (b)(4).
 
Event Description
It was reported that tissue prolapsed occurred.The patient presented with st elevation myocardial infarction (stemi).The in-stent restenosis of previously implanted stent target lesion was located in the proximal left anterior descending artery.A 3.00 x 20mm synergy ii drug-eluting stent was implanted to treat the lesion.However, tissue prolapse "tissue/plaque¿ from the area being stented extruding through the stent struts was noted.Upon post-dilation with a non-bsc balloon catheter, the tissue prolapse of the implanted stent was worsened.To cover the tissue prolapse, the physician then required a second layer stenting and the procedure was completed.No further patient complications were reported and the patient's status was stable/fine.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SYNERGY II EVEROLIMUS-ELUTING PLATINUM CHROMIUM CORONARY STENT SYSTEM
Type of Device
BIODEGRADABLE POLYMER DRUG ELUTING CORONARY STENT SYSTEM
Manufacturer (Section D)
BOSTON SCIENTIFIC - GALWAY
Manufacturer (Section G)
BOSTON SCIENTIFIC - GALWAY
Manufacturer Contact
sonali arangil
one scimed place
maple grove, MN 55311
7634941700
MDR Report Key7601308
MDR Text Key111055066
Report Number2134265-2018-05255
Device Sequence Number1
Product Code NIQ
UDI-Device Identifier08714729840176
UDI-Public08714729840176
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P150003
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,health
Reporter Occupation Physician
Type of Report Initial
Report Date 05/20/2018
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date03/07/2019
Device Model NumberH7493926020300
Device Catalogue Number39260-2030
Device Lot Number0021865560
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 05/20/2018
Initial Date FDA Received06/14/2018
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured03/07/2018
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
-
-